CIC
PMD

Crawford Investment Counsel’s Psychemedics Corporation PMD Stock Holding History

Crawford Investment Counsel’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,018
Closed -$24.2K – 282
2024
Q2 		$24.2K Sell
10,018
-6,100
-38% -$15.5K ﹤0.01% 270
2024
Q1 		$47.2K Sell
16,118
-3,980
-20% -$12.6K ﹤0.01% 270
2023
Q4 		$59.5K Sell
20,098
-12,000
-37% -$32K ﹤0.01% 267
2023
Q3 		$127K Sell
32,098
-210,015
-87% -$937K ﹤0.01% 272
2023
Q2 		$1.1M Sell
242,113
-14,236
-6% -$72K 0.02% 185
2023
Q1 		$1.35M Sell
256,349
-1,446
-0.6% -$8.02K 0.03% 178
2022
Q4 		$1.26M Sell
257,795
-9,568
-4% -$56.4K 0.03% 183
2022
Q3 		$1.72M Buy
267,363
+54
+0% +$347 0.04% 166
2022
Q2 		$1.7M Buy
267,309
+807
+0.3% +$5.17K 0.04% 172
2022
Q1 		$1.84M Hold
266,502
– – 0.04% 181
2021
Q4 		$1.87M Sell
266,502
-14,436
-5% -$115K 0.04% 175
2021
Q3 		$2.36M Sell
280,938
-10,498
-4% -$76.9K 0.05% 165
2021
Q2 		$2.03M Sell
291,436
-1,925
-0.7% -$13.5K 0.04% 173
2021
Q1 		$1.82M Sell
293,361
-6,200
-2% -$41.1K 0.04% 167
2020
Q4 		$1.52M Hold
299,561
– – 0.04% 169
2020
Q3 		$1.32M Sell
299,561
-11,605
-4% -$56.5K 0.04% 167
2020
Q2 		$1.73M Sell
311,166
-12,078
-4% -$67.5K 0.05% 152
2020
Q1 		$1.96M Sell
323,244
-995
-0.3% -$8.38K 0.07% 145
2019
Q4 		$2.97M Buy
324,239
+18,673
+6% +$172K 0.08% 146
2019
Q3 		$2.78M Buy
305,566
+2,614
+0.9% +$22.2K 0.08% 132
2019
Q2 		$3.06M Sell
302,952
-7,918
-3% -$89.9K 0.09% 124
2019
Q1 		$4.36M Buy
310,870
+13,195
+4% +$227K 0.13% 97
2018
Q4 		$4.72M Buy
297,675
+42,391
+17% +$731K 0.16% 82
2018
Q3 		$4.8M Buy
255,284
+9,743
+4% +$194K 0.15% 82
2018
Q2 		$4.72M Buy
245,541
+15,956
+7% +$323K 0.15% 82
2018
Q1 		$4.9M Sell
229,585
-1,100
-0.5% -$22.8K 0.15% 79
2017
Q4 		$4.74M Buy
230,685
+25,192
+12% +$467K 0.15% 78
2017
Q3 		$3.79M Buy
205,493
+16,260
+9% +$358K 0.12% 91
2017
Q2 		$4.72M Buy
189,233
+9,100
+5% +$191K 0.16% 79
2017
Q1 		$3.61M Buy
180,133
+29,120
+19% +$639K 0.13% 84
2016
Q4 		$3.73M Sell
151,013
-3,000
-2% -$67.2K 0.14% 88
2016
Q3 		$3.05M Sell
154,013
-21,785
-12% -$404K 0.11% 88
2016
Q2 		$2.42M Sell
175,798
-2,487
-1% -$34.6K 0.1% 89
2016
Q1 		$2.45M Sell
178,285
-100
-0.1% -$1.15K 0.1% 91
2015
Q4 		$1.81M Buy
178,385
+3,824
+2% +$41.7K 0.08% 99
2015
Q3 		$1.75M Buy
174,561
+35,600
+26% +$415K 0.08% 105
2015
Q2 		$2.06M Buy
138,961
+17,595
+14% +$274K 0.08% 102
2015
Q1 		$2.01M Buy
121,366
+10,754
+10% +$168K 0.07% 107
2014
Q4 		$1.68M Buy
110,612
+21,542
+24% +$313K 0.06% 111
2014
Q3 		$1.26M Buy
89,070
+5,200
+6% +$73.9K 0.05% 126
2014
Q2 		$1.19M Buy
+83,870
New +$1.27M 0.04% 127

Other funds holding PMD

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Crawford Investment Counsel's PMD Position: Q3 2024 in Review

Crawford Investment Counsel sold out of Psychemedics Corporation (PMD) in Q3 2024, closing a stake of 10,018 shares — an estimated $24.2K sold.

Crawford Investment Counsel first reported a position in PMD in Q2 2014 and held it in 41 quarters. The position peaked at $4.9M in Q1 2018. 21 funds tracked by Wall St. Rank hold PMD as of Q3 2024.

  • Crawford Investment Counsel reported no remaining Psychemedics Corporation position as of Q3 2024 after selling out during the quarter.
  • Crawford Investment Counsel sold 10,018 Psychemedics Corporation shares in Q3 2024, an estimated $24.2K.
  • Crawford Investment Counsel first reported a position in Psychemedics Corporation in Q2 2014 and held it in 41 quarters.
  • Crawford Investment Counsel's Psychemedics Corporation position peaked at $4.9M in Q1 2018.
  • 21 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q3 2024.

Based on Crawford Investment Counsel's 13F filing for Q3 2024, filed 14 Nov 2024.